President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
19h
Sysco allows restaurants to buy the bulk of its needs from a single source rather than dozens of producers, simplifying logistics and saving time. While the goods it sells are commodities, Sysco can ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
2don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
Independent drugstores are closing at an alarming rate, squeezed by the huge companies that reimburse pharmacies for costly ...
A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...
Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback